The activated chimeric BCR-ABL tyrosine kinase is the key biochemical defect that causes Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) [40]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.